94A-13559-67492
5 vaccinations
16 coded responses
44 check-ins
16 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 329 / FL
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Moderna
-
2021-01-14
Survey response — day 0, dose 1MedDRA: Injection site pain — Feeling: GoodFree text: Minimal injection site soreness such as with influenza vaccine. Not actual painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
-
2021-02-12
Dose 2 — Moderna
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-02-14
- 2021-02-15
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Very mild tenderness at injection site. Otherwise not painfulMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discomfort, Injection site pain — Feeling: Good · Site: PainFree text: The pain at injection site is minimal. Extremely mild to deep palpation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
-
2021-05-14
Survey response — 3 months, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: Basil Cell CarcinomaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-14
Survey response — 6 months, dose 2MedDRA: Basal cell carcinoma, Bronchitis, Cough, Dyspnoea — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Severe bronchitis with cough and sob. Basil cell carcinomaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-14
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-20
-
2021-10-24
Dose 3 — Moderna
-
2021-10-26
Survey response — days 1–6 daily, dose 3MedDRA: Vertigo — Feeling: Fair · Site: PainFree text: VertigoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Survey response — days 1–6 daily, dose 3MedDRA: Vertigo — Feeling: Fair · Site: PainFree text: VertigoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Vertigo — Feeling: Fair · Site: PainFree text: Vertigo nocturnal severeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Vertigo positional — Feeling: FairFree text: Severe vertigo after being supineMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Vertigo positional — Feeling: FairFree text: Vertigo from supine to upright persistsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-31
Survey response — day 7, dose 3MedDRA: Vertigo — Feeling: FairFree text: Vertigo persistsMedDRA releases: 2024-11 · check-in free text available
- 2021-11-07
-
2021-11-14
Survey response — day 21, dose 3MedDRA: Vertigo — Feeling: FairFree text: Vertigo which began 36 hours after Moderna booster.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-22
-
2021-11-28
Survey response — day 35, dose 3MedDRA: Nystagmus, Vertigo positional — Feeling: FairFree text: I continue to have positional objective vertigo with change from upright to supine or supine to upright. Several brief episodes of vertical nystagmus during the vertigo only as text on phone was rapidly "shuttering " vertically. I'm a physician.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — day 42, dose 3MedDRA: Vertigo positional — Feeling: FairFree text: Positional vertigo worse on a few daysMedDRA releases: 2024-11 · check-in free text available
- 2022-01-24
-
2022-04-14
Dose 4 — Moderna
- 2022-04-19
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
- 2022-05-26
-
2022-07-14
Survey response — 3 months, dose 4MedDRA: COVID-19, Cough, Malaise, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19 infection with malaise, rhino-rhea, cough and sore throatMedDRA releases: 2024-11 · check-in free text available
-
2022-07-14
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-15
- 2022-07-15
- 2022-07-18
- 2022-07-18
-
2022-10-13
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid 19MedDRA releases: 2024-11 · check-in free text available
-
2022-10-13
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-14
- 2022-10-14
- 2022-10-14
-
2022-10-20
Call successfulDoes not wish to fill out VAERS report
-
2022-10-20
Call successfulDoes not wish to fill out VAERS report
-
2022-10-20
Call successfulDoes not wish to fill out VAERS report
-
2022-11-01
Dose 5 — Moderna
- 2023-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | |
| 2 | 2021-02-12 | Moderna | |
| 3 | 2021-10-24 | Moderna | No |
| 4 | 2022-04-14 | Moderna | No |
| 5 | 2022-11-01 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 2 — day 0, dose 1
Systemic reaction (other): Minimal injection site soreness such as with influenza vaccine. Not actual pain
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Very mild tenderness at injection site. Otherwise not painful
Systemic reaction (other): The pain at injection site is minimal. Extremely mild to deep palpation.
Release 8 — 3 months, dose 2
Symptoms: Basil Cell Carcinoma
Release 9 — 6 months, dose 2
Symptoms: Severe bronchitis with cough and sob. Basil cell carcinoma
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Vertigo
Systemic reaction (other): Vertigo
Systemic reaction (other): Vertigo nocturnal severe
Systemic reaction (other): Severe vertigo after being supine
Systemic reaction (other): Vertigo from supine to upright persists
Release 10 — day 7, dose 3
Systemic reaction (other): Vertigo persists
Release 10 — day 21, dose 3
Symptoms: Vertigo which began 36 hours after Moderna booster.
Release 10 — day 35, dose 3
Symptoms: I continue to have positional objective vertigo with change from upright to supine or supine to upright. Several brief episodes of vertical nystagmus during the vertigo only as text on phone was rapidly "shuttering " vertically. I'm a physician.
Release 10 — day 42, dose 3
Symptoms: Positional vertigo worse on a few days
Release 12 — 3 months, dose 4
Symptoms: Covid-19 infection with malaise, rhino-rhea, cough and sore throat
Release 12 — 6 months, dose 4
Symptoms: Covid 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Basal cell carcinoma | ✓ | · | ✓ |
| SD | Bronchitis | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Nystagmus | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vertigo positional | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Vertigo | · | · | ✓ |
| SRO | Vertigo positional | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release